We used The Cancer Genome Atlas (TCGA), Kruskal–Wallis method, and Kaplan–Meier (KM) survival analysis to study the expression of ALKBH5 and its correlation with clinical factors in HCC. This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.